Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1997-9-19
|
pubmed:abstractText |
Acetyl-L-carnitine is known as a reservoir of activated acetyl units and as a modulator of metabolic function. The objective of this study was to quantify the fate of the acetyl moiety of acetyl-L-carnitine in lipogenic pathways. Lipogenesis was studied in an adipocyte model, differentiated 3T3-L1 cells, and a hepatoma cell, HepG2 cells. Lipogenesis and ketogenesis were examined in rat hepatocytes. Both de novo synthesis and elongation of fatty acids were investigated using gas chromatography/mass spectrometry and [1,2-(13)C]acetyl-L-carnitine. Comparisons were performed with [13C]glucose and [13C]acetate. Isotopomer Spectral Analysis, a stable isotope method for differentiating between the enrichment of the precursor and the amount of synthesis was used to analyze the data. Acetyl-L-carnitine was generally less effective than acetate as a precursor for de novo lipogenesis. The effects of acetyl-L-carnitine were not identical to those of acetate plus carnitine as expected if acetyl-L-carnitine flux to acetyl CoA is controlled by carnitine acetyl transferase. Acetyl-L-carnitine (2 mM) contributed approximately 10% of the lipogenic acetyl-CoA used for synthesis and elongation as well as 6% of the ketogenic acetyl-CoA. No differences were found between the precursor enrichment for de novo lipogenesis and for elongation of saturated fatty acids. Flux of acetyl-L-carnitine to lipid was increased, not decreased, by the ATP citrate lyase inhibitor, -hydroxycitrate. In contrast, flux of glucose to lipid was dramatically decreased by this inhibitor. These results indicate that flux of acetyl-L-carnitine to lipid can bypass citrate and utilize cytosolic acetyl-CoA synthesis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetates,
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcarnitine,
http://linkedlifedata.com/resource/pubmed/chemical/Carbon Isotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Ketone Bodies,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Palmitic Acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-2275
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1454-62
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9254070-3T3 Cells,
pubmed-meshheading:9254070-Acetates,
pubmed-meshheading:9254070-Acetylcarnitine,
pubmed-meshheading:9254070-Animals,
pubmed-meshheading:9254070-Carbon Isotopes,
pubmed-meshheading:9254070-Carcinoma, Hepatocellular,
pubmed-meshheading:9254070-Cholesterol,
pubmed-meshheading:9254070-Cytosol,
pubmed-meshheading:9254070-Fatty Acids,
pubmed-meshheading:9254070-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:9254070-Ketone Bodies,
pubmed-meshheading:9254070-Lipid Metabolism,
pubmed-meshheading:9254070-Lipids,
pubmed-meshheading:9254070-Liver Neoplasms,
pubmed-meshheading:9254070-Mice,
pubmed-meshheading:9254070-Palmitic Acid,
pubmed-meshheading:9254070-Rats,
pubmed-meshheading:9254070-Tumor Cells, Cultured
|
pubmed:year |
1997
|
pubmed:articleTitle |
Acetyl-L-carnitine flux to lipids in cells estimated using isotopomer spectral analysis.
|
pubmed:affiliation |
Department of Research, Sigma Tau S.p.A., Pomezia, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|